Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-06

Clinical Trial Update: S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of cyclosporine, daunorubicin, and cytarabine in older patients with previously untreated acute myeloid leukemia; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOSPORINE (cyclosporine)
  • CYTARABINE (CYTARABINE)
  • Daunorubicin (daunorubicin)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Leukemia | Phase 2 | Status: COMPLETED